All In MedTech

FDA Clearance Tracker · P160019-S001

Elecsys HBsAg II/Elecsys HBsAg Confirmatory Test/ PreciControl HBsAg II

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 1, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P160019-S001
Device name
Elecsys HBsAg II/Elecsys HBsAg Confirmatory Test/ PreciControl HBsAg II
Applicant location
Indianapolis, IN
Received
May 9, 2017
Decided
Nov 1, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160019

Device type

Device class
Class II
Regulation
21 CFR 866.3172

Every decision under product code LOM

FDA's approval statement

As written in FDA's record.

Approval for migration of the Elecsys HBsAg II, Elecsys HBsAg Confirmatory Test, and PreciControl HBsAg II to the cobas e 602 immunoassay analyzer.

Source documents

Other decisions for Roche Diagnostics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.